![[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]](data:image/gif;base64,R0lGODlhAQABAIAAAAAAAP///yH5BAEAAAAALAAAAAABAAEAAAIBRAA7)
Recommandé
Contenu connexe
Tendances
Tendances (20)
En vedette
En vedette (20)
Similaire à 7.Rntcp
Similaire à 7.Rntcp (20)
Plus de Prasanna Vadhanan
Plus de Prasanna Vadhanan (20)
Dernier
Dernier (20)
7.Rntcp
- 4. ORGANIZATION-PROFILE AT STATE LEVEL STATE TUBERCULOSIS OFFICE - STATE TUBERCULOSIS OFFICER STATE TUBERCULOSIS TRAINING & DEMONSTRATION CENTRE - DIRECTOR DISTRICT TUBERCULOSIS CENTRE (DTC) - DISTRICT TUBERCULOSIS OFFICER TUBERCULOSIS UNIT - MEDICAL OFFICER - SENIOR TREATMENT SUPERVISOR(STS) - SENIOR TB LAB SUPERVISOR(STLS) MICROSCOPY CENTRES AND TREATMENT CENTRES DOTS PROVIDERS
- 5. LABORATORY NETWORK CENTRAL TB DIVISION NATIONAL REFERENCE LAB STATE TB CELL INTERMEDIATE REFERENCE LAB DISTRICT TB CENTRE TU TU TU DMC II DMC I DMC III NATIONAL LEVEL STATE LEVEL DISTRICT LEVEL (SPUTUM MICROSCOPY EQA) (SUPERVISION) (FEEDBACK)
- 11. RNTCP-PHASES PHASE I (1992 – 2006) PHASE II ( 2006 – 2011 )
- 14. DRUG RESISTANCE SURVEILLANCE AIM TO DETERMINE THE PREVALENCE OF ANTI-MYCOBACTERIAL DRUG RESISTANCE AMONG -NEW CASE -TREATED CASE PLANS STATE WIDE DRS SURVEYS ICMR SURVEYS BY 2010, A NETWORK OF 24 STATE-LEVEL CULTURE AND DRUG SENSITIVITY TESTING LABORATORIES
- 15. DOTS-PLUS STRATEGY CURRENTLY UNDER DEVELOPMENT BY WHO FOR THE MANAGEMENT OF MDR-TB CASES GOAL TO PREVENT FURTHER DEVELOPMENT OF MDR-TB PRE-REQUISITE AN EFFECTIVE DOTS BASED TB CONTROL PROGRAM ORGANISATION DESIGNATED RNTCP DOTS-PLUS SITES ATLEAST 1 IN EACH STATE WITH READY ACCESS TO RNTCP ACCREDITED CULTURE AND DRUG SUSCEPTIBILITY TESTING(DST) LABORATORY
- 21. STOP TB STRATEGY VISION A WORLD FREE OF TB GOAL TO DRAMATICALLY REDUCE THE GLOBAL BURDEN OF TB BY 2015 IN LINE WITH THE MILLENNIUM DEVELOPMENT GOALS AND THE STOP TB PARTNERSHIP TARGETS